Send us a text

 Summary:  Headlines are meant to grab your attention, whether it’s about politics or sports or medicine. And so it goes for Semaglutide (Ozempic and Wegovy) and Liraglutide (Victoza and Saxenda), whose attributes have been trumpeted for weight loss, and whose possible serious side effects have recently been noted in the press.  This episode attempts to take some of the sensationalism out of the headlines and advertisements by examining Relative Risk and what it means for your actual and Absolute Risk. 

Topics:

·       Incretins 03:20

·       Gliptins 04:30

·       Ozempic Headlines 05:10

·       Absolute & Relative Risk 05:45

·       Lighting Strike Risk 06:30

·       Risk-Benefit 09:00

·       Convert to Absolute Risk 10:30

·       Pancreatitis, Stomach Paralysis, Bowel Obstruction 11:00

·       Relative Risk to Absolute Risk 16:25

·       What We Don’t Know 19:30

·       Monitor & Participate 20:30

·       Post-Marketing Monitoring/Medwatch 21:00

Questions and comments to [email protected]